Annals of internal medicine
-
Randomized Controlled Trial
In subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y, regardless of duration of recent subclinical AF episodes.
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
-
Randomized Controlled Trial
In HF with mildly reduced or preserved ejection fraction, finerenone reduced worsening HF or CV death at 32 mo.
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
-
Randomized Controlled Trial Multicenter Study
In insulin-naive T2D, weekly efsitora was noninferior to daily degludec for reducing HbA1c at 52 wk.
GIM/FP/GP: [Formula: see text] Endocrinology: [Formula: see text].
-
Randomized Controlled Trial Multicenter Study
In severe asthma with an eosinophilic phenotype, depemokimab improved exacerbations, but not quality of life, at 52 wk.
GIM/FP/GP: [Formula: see text] Allerg & Immunol: [Formula: see text] Pulmonology: [Formula: see text].
-
Randomized Controlled Trial
In asymptomatic severe AS, early surgery vs. conservative therapy reduced a composite of death, MI, stroke, or HF hospitalization at 63 mo.
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].